Stallergenes chooses Magic Software's iBOLT integration platform

NewsGuard 100/100 Score

Magic Software Enterprises Ltd. (NASDAQ: MGIC), a global provider of mobile and cloud-enabled application and business integration platforms, announced today that Stallergenes, a biopharmaceutical company and world leader in the treatment of severe allergic respiratory illnesses, has chosen Magic Software's iBOLT integration platform to integrate its various purchasing systems with its SAP ERP.

In 2005, Stallergenes used iBOLT to build an online prescription tracking service that streamlined its back-office information flows. Following this successful implementation, Stallergenes has now launched a new project, once again using Magic's technology, to optimize communication between its purchasing and ERP systems. iBOLT linked Stallergenes' disparate systems, enabling them to automatically convert purchase orders and entries from its Lawson M3 ERP, hosted on an AS/400 server (IBM System i), before integrating them into the company's SAP Financials management system.

"iBOLT serves as the communication hub for our various applications. It is our 'orchestra conductor', communicating natively with our various systems," comments Thierry Gréhaigne, CIO of Stallergenes. "It has enabled us to optimize our workflows, making them reliable and completely transparent for users, whether they are at our French, German, or Italian site."

"For more than five years now, iBOLT has enabled us to implement a high-performance, paperless infrastructure," he adds. "Because it has always been able to safeguard existing systems, we can look ahead to future technological changes with confidence."

"We are very pleased that Stallergenes has once again chosen Magic Software's products," said Guy Bernstein, CEO of Magic Software. "Magic Software's iBOLT business integration platform has again proven its ease-of-use and ability to deliver rapid time-to-market integration solutions."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DELiVR's virtual reality training speeds up cell detection in complex brain datasets